Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-23

Clinical Trial Update: Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concurrent paclitaxel and radiation in breast cancer with analysis of tumor profiles and pathologic response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-23